期刊文献+

CA_(15-3)RIA对乳腺癌和乳腺癌术后复发的诊断价值 被引量:2

Diagnostic value of CA_(15-3) RIA in breast cancer and its recurrence after operation
下载PDF
导出
摘要 用CA15I-3RIA测定了41例术前乳腺肿瘤和113例乳腺癌术后患者的血清。其中,术前25例为乳腺癌,其灵敏度为20.0%,特异性为93.7%;59例诊断为乳腺癌术后复发者,灵敏度为71.2%。50例诊断为骨转移者,灵敏度为78.0%.结果表明:由于CA15-3对早期乳腺癌的灵敏度较低,不适于作乳腺癌普查。但是,它对于乳腺癌术后复发、转移,尤其是对骨等脏器的转移具有较高的诊断价值。 Serum CA15-3 levels of 41 pre-operative patients with breast tumor and 113post-operative patients with breast cancer were meassured by radioimmunoassay.The sensitivity and specificity were 20%, 93.7%, and 71.2%, respectively. In 50patients with bone metastasis, the sensitivity was 78.0%. It appears that due to itslow sensitivity for early diagnosis, CA15-3 RIA has little use for screening in generalpopulation to detect primary breast cancer in early stage but is benefical fordetecting its metastasis and recurrence.
出处 《核技术》 CAS CSCD 北大核心 1998年第5期307-309,共3页 Nuclear Techniques
关键词 放射免疫测定 乳腺癌 转移 术后复发 诊断 CA_(15-3), Radioimmunoassay, Breast cancer, Metastasis
  • 相关文献

参考文献4

  • 1E. Vizcarra,A. Lluch,R. Cibrián,F. Jarque,V. Alberola,V. Belloch,J. García-Conde. Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis[J] 1996,Breast Cancer Research and Treatment(3):209~216
  • 2Peter L. Devine,Maree A. Duroux,Rachel J. Quin,Michael A. McGuckin,Gloria J. Joy,Bruce G. Ward,Clifford W. Pollard. CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer[J] 1995,Breast Cancer Research and Treatment(3):245~251
  • 3Hirotaka Iwase,Shunzo Kobayashi,Yukashi Itoh,Hideki Fukuoka,Tatsuya Kuzushima,Hiroji Iwata,Toshinari Yamashita,Akihiro Naitoh,Kazuko Itoh,Akira Masaoka. Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer[J] 1995,Breast Cancer Research and Treatment(1):83~88
  • 4Rafael Molina,Gabriel Zanón,Xavier Filella,Ferran Moreno,Judith Jo,Montserrat Daniels,Maria L. Latre,Nuria Giménez,Jaume Pahisa,Martín Velasco,Antonio M. Ballesta. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients[J] 1995,Breast Cancer Research and Treatment(1):41~48

同被引文献8

  • 1徐鑫川,万卫星.核素骨显像诊断转移性骨肿瘤的价值[J].中华核医学杂志,1993,13(1):37-38. 被引量:14
  • 2李伟,屈婉莹,陈雅清,薛翠英.临床分期和病理类型对乳腺癌骨转移率的影响[J].中华核医学杂志,1995,15(3):199-199. 被引量:12
  • 3Soloway MS,Hardeman SW,Hickey D,et al.Stratification of patients with metastatic cancer based on extent of disease on initial bone scan[J].Cancer,1988,61 (1):195 ~ 202
  • 4Hayes DF,Zurawski VR,Wufe DW,et al.Comparison of circulting CA15-3 and carcinoembryonic antients with breast cancer[J].J Clin Oncol,1986,4(10):1542 ~ 1550
  • 5Baker RR,Holmes ER,Alderson Po,et al.An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer[J].Ann Surg,1997,186(3):363 ~ 367
  • 6HayesDF<ZurawskiVR,WufeDW,etal.ComparisonofcircultingCA15-3andcarcinoembryonicantigenlevelsinaptientswithbreastcancer[J].JClinOncol,1986,4(10):1542-1550.
  • 7邹永盛 常克力 庞雁 等.放射性核素显像早期诊断骨转移瘤85例[J].中华核医学杂志,1992,12(4):235-235.
  • 8翟全宜 黄淮 周建国 等.恶性肿瘤显像非转移性浓聚分析.中华核医学杂志,1995,15(3):190-190.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部